In a study of 20 patients, scientists found that a combination of atomoxetine and oxybutynin reduces AHI, reports Science.

The trial turned up one potentially problematic finding: Although the drug combination reduced patients’ AHIs, their number of subconscious arousals—the subtle awakenings that leave patients exhausted—remained high.